CVE-2024-52378: LABS64 Digipass

High severity, CVSS 7.5. EPSS: 0.6% chance of exploitation in the next 30 days.

Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in labs64 DigiPass digipass allows Absolute Path Traversal.This issue affects DigiPass: from n/a through <= 0.3.0.

Affected products

• LABS64 Digipass: up to and including 0.3.0

Published 2024-11-14. Last modified 2026-06-17.